The results show that leonurine changed the gene and lipid profiles of NAFLD in mice, and preliminarily verified that leonurine may have an anti-NAFLD effect through phosphorylation of the ADRA1a/AMPK/SCD1 axis. This evidence concerns the gene ADRA1A and metabolic dysfunction-associated steatotic liver disease.